A phase 2 trial of 9MW2821 monotherapy in patients with cervical cancer
Latest Information Update: 24 Jan 2025
Price :
$35 *
At a glance
- Drugs 9MW 2821 (Primary)
- Indications Cervical cancer
- Focus Therapeutic Use
- 24 Jan 2025 New trial record
Latest Information Update: 24 Jan 2025